Literature DB >> 22934475

[Organized screening for colorectal cancer: challenges and issues for a Swiss pilot study].

J-L Bulliard1, C Ducros, F Levi.   

Abstract

Colorectal cancer is among the three most common and lethal neoplasms in Switzerland (about 4,000 new cases and 1,600 deaths per year, respectively). Several screening modalities are available. The effectiveness of colorectal cancer screening on mortality is established. The implementation of a successful screening intervention shall follow specified phases and conditions, and abide with global principles: pooling and coordinating efforts from all partners, setting goals and priorities, and identifying action plans. A feasibility (pilot) study is needed to verify requirements for quality, effectiveness, efficiency and innocuousness. Endeavours towards implementing a pilot programme for colorectal cancer screening in the Vaud canton (Switzerland) are presented and discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22934475

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  3 in total

1.  Training primary care physicians to offer their patients faecal occult blood testing and colonoscopy for colorectal cancer screening on an equal basis: a pilot intervention with before-after and parallel group surveys.

Authors:  Kevin Selby; Jacques Cornuz; David Gachoud; Jean-Luc Bulliard; Cristina Nichita; Gian Dorta; Cyril Ducros; Reto Auer
Journal:  BMJ Open       Date:  2016-05-13       Impact factor: 2.692

2.  Self-reported screening practices of family physicians participating in the colorectal cancer screening program of the canton of Vaud: a cross-sectional study.

Authors:  Camille Poroes; Jacques Cornuz; Alexandre Gouveia; Cyril Ducros; Kevin Selby
Journal:  BMC Fam Pract       Date:  2020-06-10       Impact factor: 2.497

3.  Offering patients a choice for colorectal cancer screening: a quality improvement pilot study in a quality circle of primary care physicians.

Authors:  Yonas Martin; Leo Alexander Braun; Marc-Andrea Janggen; Kali Tal; Nikola Biller-Andorno; Cyril Ducros; Kevin Selby; Reto Auer; Adrian Rohrbasser
Journal:  BMJ Open Qual       Date:  2019-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.